Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non–Small Cell Lung CancerRui Li, Xingming Deng, Zhongliang Hu et al.|Molecular Cancer Therapeutics|2013Cited by 156
Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer TherapyBingshe Han, Xingming Deng, Walter J. Curran et al.|Cancer Cell|2015Cited by 136
Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck CancerRui Li, Xingming Deng, Shuo You et al.|PLoS ONE|2013Cited by 89
Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradationChaoyun Pan, Sumin Kang, Jaemoo Chun et al.|Journal of Clinical Investigation|2019Cited by 44
Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenograftsShijun Zhu, Mamoru Shoji, Terry W. Moore et al.|Integrative Biology|2012Cited by 40